Post by
1northumberland on Oct 26, 2023 11:56am
Ibalozumab
THTX- this is a monoclonal antibody antiretroviral therapy commercialized in the U. S under the name of TROFARZO, as an optimized background regimens in heavily treatment- experienced people with HIV.
Short sighted investors getting too emotional about the stock.
Lots of good things happening at THTX, including the above HIV drug.
buy low!
Comment by
Trogarzon on Oct 26, 2023 12:00pm
Hey it's a given those who bought this at 1$ imagine they can at least make a buck on top of it. So yes it's worth a look if you can afford to loose it.